Global Orthobiology Market Trends, Applications, Analysis, Growth, and Forecast: 2017 to 2026

MarketResearch.biz delivers in-depth insights on the global orthobiology market in its upcoming report titled, “Global Orthobiology Market Trends, Applications, Analysis, Growth, and Forecast: 2017 to 2026”. The global orthobiology market is estimated to register a CAGR of X.X% in terms of value during forecast period 2017–2026. The report offers in-depth insights, revenue details, and other vital information regarding the global orthobiology market, and the various trends, drivers, restraints, opportunities, and threats in the target market till 2026. The report offers insightful and detailed information regarding the various key players operating in the global orthobiology market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global orthobiology market report has been segmented on the basis of types, end user, and region.

Orthobiologics are substances used by orthopaedic surgeon to heal injuries such as cartilages, bones, muscles, tendons, ligaments, and nerves. These products are made from substances that are naturally found in body, substances such as platelet rich plasma, stem cells, extra cellular membrane. When used in higher concentration may help speed up healing process.

Increasing incidence of accidents among general population is a key factor driving growth of the global orthobiology market. In addition, increase in injuries such as shoulder dislocation, acl tear, distal radius fracture among sport people, rising demand for minimal invasive surgeries among elderly people for meniscus tear, and minimizing degenerative diseases are other factor expected to fuel growth of the global orthobiology market.

However, high cost of treatment is a key factor restraining growth of the global orthobiology market. Additionally, stringent government regulation for product approval is other major factor expected to hamper growth of the global orthobiology market over the forecast period.

Increasing R&D activities and innovation in cost effective orthobiology products is expected to present new opportunities for major market players in the global orthobiology market.

North America market is a dominant player in the global orthobiology market and accounts for largest market share in terms of revenue as compared to that of markets in other regions. This is attributed to well-developed healthcare industry, presence of leading orthobiological manufacturers, and rise in number of injuries related to ankles, knees, etc. Europe accounts for the second largest revenue share contribution to the global orthobiology market followed by markets in Asia Pacific, Latin America, and Middle East & Africa respectively. The market in Asia Pacific is projected to have the fastest growth in terms of revenue, owing to increase in number of accidents and growing preferences of minimal invasive surgeries related to spine, shoulder, hip, etc., and rise in government initiatives for the improvement of orthopedic surgeries in healthcare sector in the region.

Market Segmentation:

Global Orthobiology Market Segmentation, by Product:

• Bone Allograft
• Stem Cell Therapy
• Bone Graft Substitutes
• Bone Growth Factors & Spinal Stimulation
• Viscosupplementation

Global Orthobiology Market Segmentation, by End-user:

• Hospitals
• Orthopaedic Clinics
• Other End Users

Global Orthobiology Market Segmentation, by Region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

• Allograft Tissue Systems, Inc.
• Baxter International Inc.
• Berkeley Advanced Biomaterials, Inc.
• Bone Biologics Corporation
• Bone Solutions, Inc.
• Medtronic, Inc.
• Osiris Therapeutics, Inc.
• Smith & Nephew plc
• Stryker Corporation
• Kinetic Concepts, Inc.
• Pioneer Surgical Technology, Inc.